Literature DB >> 23590015

The prevalence of high sodium intake among hypertensive patients at hypertension clinic, Siriraj Hospital.

Peera Buranakitjaroen1, Meta Phoojaroenchanachai.   

Abstract

OBJECTIVE: To find the prevalence of excessive salt intake among hypertensive patients in hypertension (HT) clinic at Siriraj Hospital. In addition, to correlate the epidemiologic characteristics of the studied group with high salt diet. MATERIAL AND
METHOD: A cross-sectional study was conducted among 320 hypertensive patients in HT clinic at Siriraj Hospital from September 2010 to January 2011. Epidemiologic data, e.g., age, sex, body mass index, duration of treatment, education level, salary, frequency of salty food consumed/week and clinical data, e.g., renal function, (creatinine clearance, CCr) and anti-hypertensive drug(s) received were collected using pre-defined questionnaires. All volunteers were asked to collect 24-hour urine for 2 days to determine average daily amount of urine sodium (UNa). Those 24-hour UNa > or = 100 mmol/ day were considered high salt intake. Correlations of high daily salt intake with all data collected were done.
RESULTS: The prevalence of high salt intake was 73.4%. The mean total daily Na intake was 148 mmol/day i.e. 3.4 g of Na/day When the influence of clinical characteristics on the risks of high salt intake was carried out, there were 2.42, 4.00 and 2.88 fold increases among those who have higher education level, those who have CCr > or = 60 ml/min/1.73 m2, and those who knew that salt could increase blood pressure (BP), respectively. About three-quarters (76.3%) of those patients who knew the effect of salt on BP consumed high salt diet.
CONCLUSION: The present study revealed that nearly three-quarters of hypertensive patients who attended the HT clinic still consumed high salt diet. Most patients who knew the effect of dietary salt on BP level ignored restriction about salt intake. In addition, those patients with higher education and CCr > or = 60 ml/min/1.73 m2 also consumed high Na diet.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23590015

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  5 in total

1.  Influence of salty food preference on daily salt intake in primary care.

Authors:  Kazuhiro Takamura; Masanobu Okayama; Taro Takeshima; Shinji Fujiwara; Masanori Harada; Junichi Murakami; Masahiko Eto; Eiji Kajii
Journal:  Int J Gen Med       Date:  2014-04-15

2.  Dietary Salt-Related Determinants of Hypertension in Rural Northern Thailand.

Authors:  Pimbucha Rusmevichientong; Celina Morales; Gabriela Castorena; Ratana Sapbamrer; Mathuramat Seesen; Penprapa Siviroj
Journal:  Int J Environ Res Public Health       Date:  2021-01-06       Impact factor: 3.390

3.  Estimation of sodium consumption by novel formulas derived from random spot and 12-hour urine collection.

Authors:  Pitchaporn Sonuch; Surasak Kantachuvesiri; Prin Vathesatogkit; Raweewan Lappichetpaiboon; Worawan Chailimpamontri; Nintita Sripaiboonkij Thokanit; Wichai Aekplakorn
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

4.  Food Choices and Hypertension Among Rural Thais: Evidence From a Discrete Choice Experiment.

Authors:  Pimbucha Rusmevichientong; Helen Nguyen; Celina Morales; Jessica Jaynes; Michele M Wood
Journal:  Int J Public Health       Date:  2022-07-15       Impact factor: 5.100

5.  Estimated dietary sodium intake in Thailand: A nationwide population survey with 24-hour urine collections.

Authors:  Worawon Chailimpamontree; Surasak Kantachuvesiri; Wichai Aekplakorn; Raweewan Lappichetpaiboon; Nintita Sripaiboonkij Thokanit; Prin Vathesatogkit; Ananthaya Kunjang; Natthida Boonyagarn; Penmat Sukhonthachit; Narinphop Chuaykarn; Patthrapon Sonkhammee; Payong Khunsaard; Phassakon Nuntapanich; Pattaraporn Charoenbut; Comsun Thongchai; Apinya Uttarachai; Wisrut Kwankhoom; Fuangfah Rattanakanahutanon; Krich Ruangchai; Nadchar Yanti; Natnapa Sasang; Sushera Bunluesin; Renu Garg
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-01-08       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.